Skip to main content
. 2024 Nov 12;20(3):240004. doi: 10.1183/20734735.0004-2024

TABLE 6.

Treatment in extensive stage small cell lung cancer

First-line treatment 4 cycles Carboplatin+etoposide+atezolizumab Maintenance atezolizumab
4 cycles Platinum+etoposide+durvalumab Maintenance durvalumab
4–6 cycles Carboplatin+etoposide
Carboplatin+oral topotecan
Cisplatin+irinotecan
Second-line treatment Oral or i.v. topotecan